REGEMAT 3D
Bioprinting Firm REGEMAT3D Preps for IPO with Crowdfunding Campaign
In 2022, Spanish biotech company REGEMAT 3D will open an equity crowdfunding campaign on Crowdcube to add to the €402,500 ($457,000) raised during its first financing round. The funds will…
3D Printing News Briefs: November 15, 2019
In today’s 3D Printing News Briefs, we’re sharing stories about new partnerships, a new material, and a new system for safe powder handling. EOS and AMFG have announced a partnership,…
Pharmaceutical Researchers Use REGEMAT 3D Technology for Drug Delivery
3D bioprinting is becoming an interesting alternative for medical professionals and research institutions that choose a more personalized treatment for their patients, this has potential to improve the quality of…
REGEMAT 3D Will Start Selling Biomaterials
One of the key players in the bioprinting field in Spain will be incorporating seven new biomaterials. In the coming months, REGEMAT 3D will launch a catalog of biomaterials that customers…
Interview with Jose Manuel Baena of Regemat 3D and Breca Health Care
This is an interview with Jose Manuel Baena of Regemat 3D and Breca Health Care. These organizations are doing various work in the bio-printing sector as well as the medical device sector.
Spanish Company BRECA Health Care is at the Forefront of Medical Devices & Bioprinting
In 2018 Spain’s health care system ranked third in the world, behind Hong Kong and Singapore, and first in Europe according to a Bloomberg study, so it’s no wonder that…
REGEMAT 3D Offers Customized Options for 3D Bioprinting
There are a few companies that immediately come to mind when 3D bioprinting is mentioned- Organovo and EnvisionTEC among them, for example. But bioprinting isn’t just the domain of a few…
